tradingkey.logo

Qiagen NV

QGEN

49.230USD

+0.260+0.53%
終値 08/13, 16:00ET15分遅れの株価
10.67B時価総額
113.95直近12ヶ月PER

Qiagen NV

49.230

+0.260+0.53%
詳細情報 Qiagen NV 企業名
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
企業情報
企業コードQGEN
会社名Qiagen NV
上場日Sep 01, 1996
最高経営責任者「CEO」Mr. Thierry Bernard
従業員数5765
証券種類Ordinary Share
決算期末Sep 01
本社所在地Hulsterweg 82
都市VENLO
証券取引所NYSE Consolidated
Netherlands
郵便番号5912 PL
電話番号31773556600
ウェブサイトhttps://www.qiagen.com/
企業コードQGEN
上場日Sep 01, 1996
最高経営責任者「CEO」Mr. Thierry Bernard
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
事業別USD
会社名
収益
比率
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
地域別USD
会社名
収益
比率
United States
232.85M
48.16%
Europe & Middle East & Africa
160.64M
33.23%
Asia, Pacific & Rest of the World
68.83M
14.24%
Other Americas
21.13M
4.37%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
株主
更新時刻: 3 hours ago
更新時刻: 3 hours ago
株主統計
種類
株主統計
株主統計
比率
Wellington Management Company, LLP
11.29%
MFS Investment Management
10.84%
BlackRock Institutional Trust Company, N.A.
9.36%
The Vanguard Group, Inc.
4.23%
T. Rowe Price International Ltd
1.92%
Other
62.37%
株主統計
株主統計
比率
Wellington Management Company, LLP
11.29%
MFS Investment Management
10.84%
BlackRock Institutional Trust Company, N.A.
9.36%
The Vanguard Group, Inc.
4.23%
T. Rowe Price International Ltd
1.92%
Other
62.37%
種類
株主統計
比率
Investment Advisor/Hedge Fund
41.84%
Investment Advisor
33.28%
Research Firm
3.18%
Hedge Fund
3.12%
Sovereign Wealth Fund
1.87%
Pension Fund
1.56%
Holding Company
1.17%
Bank and Trust
1.03%
Individual Investor
0.44%
Other
12.51%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Wellington Management Company, LLP
24.44M
11.29%
+1.15M
+4.92%
Mar 31, 2025
MFS Investment Management
24.26M
11.2%
+24.26M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.17M
9.31%
-350.47K
-1.71%
Jun 16, 2025
The Vanguard Group, Inc.
8.78M
4.06%
+245.16K
+2.87%
Mar 31, 2025
T. Rowe Price International Ltd
4.15M
1.92%
+4.01M
+2888.12%
Mar 31, 2025
Amundi Asset Management, SAS
4.19M
1.94%
-516.05K
-10.96%
Mar 31, 2025
EARNEST Partners, LLC
3.81M
1.76%
+3.81M
--
Mar 31, 2025
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
Swedbank Robur Fonder AB
3.06M
1.41%
+186.76K
+6.51%
May 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
First Trust Nasdaq Lux Digi Health Solutions ETF
4.68%
Global X Genomics & Biotechnology ETF
4.46%
Invesco Biotechnology & Genome ETF
2.91%
Franklin Genomic Advancements ETF
1.86%
VanEck Biotech ETF
1.73%
ROBO Global Healthcare Technology & Innovation ETF
1.55%
iShares Health Innovation Active ETF
1.07%
Pacer US Large Cap Cash Cows Growth Leaders ETF
1.06%
Harbor Long-Short Equity ETF
0.99%
FlexShares US Quality Low Volatility Index Fund
0.85%
詳細を見る
First Trust Nasdaq Lux Digi Health Solutions ETF
比率4.68%
Global X Genomics & Biotechnology ETF
比率4.46%
Invesco Biotechnology & Genome ETF
比率2.91%
Franklin Genomic Advancements ETF
比率1.86%
VanEck Biotech ETF
比率1.73%
ROBO Global Healthcare Technology & Innovation ETF
比率1.55%
iShares Health Innovation Active ETF
比率1.07%
Pacer US Large Cap Cash Cows Growth Leaders ETF
比率1.06%
Harbor Long-Short Equity ETF
比率0.99%
FlexShares US Quality Low Volatility Index Fund
比率0.85%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
日付
種類
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
tradingkey.logo
tradingkey.logo
当社が提供する日中データはRefinitivより配信されており、同社の利用規約が適用されます。終値データ(過去・現在)についてもRefinitivより提供されています。全ての相場情報は現地取引所時間で表示されます。米国株式のリアルタイム最終取引価格はNasdaqを通じて報告された取引のみを反映しています。日中データは最低15分遅れ、または各取引所の要件に準じて遅延配信されます。
* 当コンテンツ(分析資料・取引戦略等)は第三者プロバイダーであるTrading Centralより提供されており、記載の見解は分析官の独立した評価及び判断に基づくものです。投資家個々の投資目的や財務状況は考慮されておりません。
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。
KeyAI